Free Trial

POINT Biopharma Global (PNT) Insider Trading & Ownership

→ “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad)
Free PNT Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media

POINT Biopharma Global (NASDAQ:PNT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.00%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
$229,158.00
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$4.24 M
Get PNT Insider Trade Alerts

Want to know when executives and insiders are buying or selling POINT Biopharma Global stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PNT Insider Buying and Selling by Quarter

Ad Stansberry Research
“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
Find out why right here (and see what you can do to get in too with just a few dollars).

POINT Biopharma Global Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/29/2022Joe A MccannCEOBuy2,160$6.64$14,342.40  
11/21/2022Yael MargolinDirectorBuy1,710$6.56$11,217.60  
11/18/2022Jonathan R GoodmanDirectorBuy6,000$6.33$37,980.00  
11/17/2022Allan C SilberChairmanBuy27,603$6.00$165,618.00  
5/25/2022Neil E FleshnerInsiderSell564,204$7.51$4,237,172.04  
(Data available from 1/1/2013 forward)

PNT Insider Trading Activity - Frequently Asked Questions

Who is on POINT Biopharma Global's Insider Roster?

The list of insiders at POINT Biopharma Global includes Allan C Silber, Joe A Mccann, Jonathan R Goodman, Neil E Fleshner, and Yael Margolin. Learn more on insiders at PNT.

What percentage of POINT Biopharma Global stock is owned by insiders?

16.00% of POINT Biopharma Global stock is owned by insiders. Learn more on PNT's insider holdings.

Which POINT Biopharma Global insiders have been buying company stock?

The following insiders have purchased PNT shares in the last 24 months: Allan C Silber ($165,618.00), Joe A Mccann ($14,342.40), Jonathan R Goodman ($37,980.00), and Yael Margolin ($11,217.60).

How much insider buying is happening at POINT Biopharma Global?

Insiders have purchased a total of 37,473 PNT shares in the last 24 months for a total of $229,158.00 bought.

Which POINT Biopharma Global insiders have been selling company stock?

The following insider sold PNT shares in the last 24 months: Neil E Fleshner ($4,237,172.04).

How much insider selling is happening at POINT Biopharma Global?

Insiders have sold a total of 564,204 POINT Biopharma Global shares in the last 24 months for a total of $4,237,172.04 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:PNT) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Fed launches fourth dollar overhaul
Stansberry Research
The only accurate crypto trading system I know …
Weiss Ratings
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
GoldenCrest Metals